IPF Treatment: Exploring Novel Approaches for Disease Modification
- Inhaled antisense as a novel paradigm for lung therapeutics
- Advancing innovative technology enables the targeting, interrogation, and validation of genes associated with IPF that may be difficult to reach with other approaches
- Exploring MUC5B as a Novel IPF Target: Pros, Cons, and Proof-of-Concept Data